"We are excited to share that the Zepbound single-dose vials are now here, further delivering on our promise to increase supply of Zepbound in the U.S.," said Patrik Jonsson, executive vice president, and president of Lilly Cardiometabolic Health and Lilly USA
Mounjuro tirzepatide injections are the first of their kind for the treatment of diabetes and work very well for weight loss

Patients should be advised to: Inspect feet daily for injuries, blisters, or colour changes Wear well-fitting footwear and avoid walking barefoot Maintain good foot hygiene and moisturise dry skin (avoiding between toes) Seek same-day assessment by the multidisciplinary foot care service for any new foot wounds, signs of infection, or sudden changes in foot shape Attend annual diabetes reviews incorporating the Nine Care Processes, including foot screening Referral to specialist services is appropriate when: Neuropathic pain remains inadequately controlled despite optimised primary care management Diagnostic uncertainty exists regarding neuropathy aetiology, or features are atypical or rapidly progressive Foot ulceration, infection, or suspected Charcot arthropathy develops (same-day referral to multidisciplinary foot care service per NICE NG19) Severe infection or critical limb ischaemia (emergency hospital admission) Severe autonomic symptoms significantly impair quality of life Patient engagement through diabetes self-management education empowers individuals to optimise lifestyle factors including diet, physical activity, and smoking cessationall contributing to improved metabolic control and reduced complication risk

Freezing reconstituted tirzepatide causes purity damage
The products might be perfectly fine